Meanwhile, the amount of distressed debt is small and is concentrated in the low single B/CCC part of the market, so we don’t expect it to become a systemic concern. For the
Events don’t obey the convenient constraints of calendar years. As 2025 appears on the horizon, fund managers, traders, central bankers, and retail investors are discovering that “higher for longer” may mean years
Many hot trends have been turned into equity portfolios. But fads aren’t investing themes and may be flawed as standalone investments. What do pet lovers, Korean pop music and sin stocks have
The Global Macro & Asset Allocation team led by Henry McVey recently published its Outlook for 2025: Glass Still Half Full sharing our comprehensive views on the macro and geopolitical backdrop and
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. As a result, the sector’s share of the MSCI World benchmark shrank to
Chimera Investment ( (CIM) ) just unveiled an update. On March 3, 2025, Chimera Investment Corporation participated in the RBC Capital Markets Global Financial Institutions Conference, where it made available an investor
44 Inward investment opportunities between the UK and China were the focus of the second panel of the day at the UK-China Business Forum 2025 on 5 March Chaired by Huang Shan,
Opinions expressed by Entrepreneur contributors are their own. You’re reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media. After thirty years in the finance world, Geoff Robinson saw something missing in
Market Commentaries | January 20, 2025 Read our latest quarterly Investment Outlook and Portfolio Strategy document, providing a financial market recap for Q4 and our outlook for the next 12-18 months. While
US small-cap stocks have historically performed well in the months following US presidential elections, regardless of the balance of power (Display). If history repeats itself, this trend could be especially pronounced in
Asset managers face a challenging backdrop when bringing new products to market amid macro and regulatory upheaval, while investors navigate their allocations to burgeoning product sets across active and ESG ETFs. This